News
Japan Approves GSK’s Bepirovirsen as First Functional Cure for Chronic Hepatitis B
The approval marks the first global approval for bepirovirsen, and makes Hibsago the first and only treatment approved in Japan as a functional cure for chronic hepatitis B.
imphoenix82
- August 24, 2026
- 0 Comments
- 75 Views
-
